Corrie, P. G., Marshall, A., Nathan, P. D., Lorigan, P., Gore, M., Tahir, S., . . . Middleton, M. R. (2018). Adjuvant bevacizumab for melanoma patients at high risk of recurrence: Survival analysis of the AVAST-M trial. Ann Oncol.
استشهاد بنمط شيكاغوCorrie, P G., et al. "Adjuvant Bevacizumab for Melanoma Patients At High Risk of Recurrence: Survival Analysis of the AVAST-M Trial." Ann Oncol 2018.
MLA استشهادCorrie, P G., et al. "Adjuvant Bevacizumab for Melanoma Patients At High Risk of Recurrence: Survival Analysis of the AVAST-M Trial." Ann Oncol 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.